Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA
Clotblog with Dr Samuel Goldhaber
View all posts »Aspirin for stroke prevention in AF: More risk than benefit?
Nov 4, 2011 15:50 EDT-
1Comments
-
Read later
On the heels of a large Danish cohort study that indicated that aspirin had little effect in stroke prevention for patients with atrial fibrillation and with the rise of promising novel anticoagulants, what role is there for aspirin as an agent to prevent stroke?
See also:
Aspirin should not be used for stroke prevention in AF patients
Olesen JB, Lip GYH, Lindardsen J, et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study. Thromb Haemost 2011; 106:739-749. Abstract.
Your comments
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
||
|
||||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
